Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Low-potency steroids can cause serious side effects in people with skin conditions like Netherton syndrome.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Vitamin D3 analogs can promote hair growth in mice genetically prone to hair loss.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Hair loss requires customized treatments based on its various causes and types.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.